Richards Barry Joyce & Partners has represented Intercontinental R.E. Corp. in an 88,930 s/f lease with ImmunoGen, Inc. at 830 Winter St.
830 Winter St. is comprised of 182,106 s/f and ImmunoGen will occupy office and laboratory space on three floors. ImmunoGen will be moving to Waltham from its headquarters in East Cambridge.
"830 Winter St. is one of the top laboratory facilities in the Greater Boston suburbs," said Thomas Taranto, director, head of asset and portfolio management at Intercontinental.
Jon Varholak, Michael Frisoli and Ron Friedman of RBJ represented Intercontinental.
Roy Hirshland and Mike Shreve of T3 Advisors represented ImmunoGen.
"Boston's suburbs continue to attract biotechnology companies, with Waltham and Lexington at the forefront of this trend," said Varholak, partner, RBJ. "The scarcity of opportunitiesin Cambridge, which was created by the tremendous growth of Boston as a hub of biotechnology, has helped fuel the growth of biotech in the suburbs."